AMW GmbH
AMW GmbH is a specialized pharmaceutical company based in Germany that develops and manufactures biodegradable drug delivery systems, including implantable products like Goserelin and Leuprorelin for hormone-sensitive tumors. The company covers the entire pharmaceutical value chain with state-of-the-art production facilities and offers contract development and manufacturing services (CDMO/CMO) under GMP regulations. AMW focuses on innovative, cost-effective therapies to improve patient adherence and collaborates with global pharmaceutical partners. It employs advanced extrusion technology and integrates AI in formulation development, achieving record revenues and operational profitability, positioning itself as a leading provider of controlled drug delivery systems.
AMW GmbH
AMW GmbH is a specialized pharmaceutical company based in Germany that develops and manufactures biodegradable drug delivery systems, including implantable products like Goserelin and Leuprorelin for hormone-sensitive tumors. The company covers the entire pharmaceutical value chain with state-of-the-art production facilities and offers contract development and manufacturing services (CDMO/CMO) under GMP regulations. AMW focuses on innovative, cost-effective therapies to improve patient adherence and collaborates with global pharmaceutical partners. It employs advanced extrusion technology and integrates AI in formulation development, achieving record revenues and operational profitability, positioning itself as a leading provider of controlled drug delivery systems.